GSK makes Emma Walmsley most powerful woman in FTSE 100

GlaxoSmithKline has appointed Emma Walmsley as chief executive, who will be taking over from Sir Andrew Witty when he retires in March 2017 after eight years at the company. Ketan Patel, portfolio manager at EdenTree comments in The Guardian, claiming that the appointment makes Emma Walmsley the most powerful woman in the FTSE 100.